1.Aubin, F, Puzenat, E, Arveux, P, Louvat, P, Quencez, E, Humbert, P. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol 2001; 144: 1204–1206.
2.Hymes, DR, Strom, EA, Fife, C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54: 28–46.
3.Wagamon, K, Li, LJ. Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report. Dermatol Surg 2007; 33: 117–119.
4.Lichter, MD, Karagas, MR, Mott, LA, Spencer, SK, Stukel, TA, Greenberg, ER. Therapeutic ionizing radiation and the incidence of BCC and SCC. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000; 136: 1007–1011.
5.Karagas, MR, McDonald, JA, Greenberg, ER, Stukel, TA, Weiss, JE, Baron, JA, Stevens, MM. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88: 1848–1853.
6.Davis, MM, Hanke, CW, Zollinger, TW, Montebello, JF, Hornback, NB, Norins, AL. Skin cancer in patients with chronic radiation dermatitis. J Am Acad Dermatol 1989; 20: 608–616.
7.Bonner, JA, Harari, PM, Giralt, J, Azarnia, N, Shin, DM, Cohen, RB, Jones, CU, Sur, R, Raben, D, Jassem, J, Ove, R, Kies, MS, Baselga, J, Youssoufian, H, Amellal, N, Rowinsky, EK, Ang, KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567–578.
8.Bölke, E, Gerber, PA, Lammering, G, Peiper, M, Müller-Homey, A, Pape, H, Giro, C, Matuschek, C, Bruch-Gerharz, D, Hoffmann, TK, Gripp, S, Homey, B, Budach, W. Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab. Strahlenther Onkol 2008; 184: 105–110.
9.Milano, MT, Vokes, EE, Kao, J, Jackson, W, List, MA, Stenson, KM, Witt, ME, Dekker, A, MacCracken, E, Garofalo, MC, Chmura, SJ, Weichselbaum, RR, Haraf, DJ. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 2006; 28: 1141–1151.
10.Mosterd, K, Krekels, GA, Nieman, FH, Ostertag, JU, Essers, BA, Dirksen, CD, Steijlen, PM, Vermeulen, A, Neumann, H, Kelleners-Smeets, NW. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol 2008; 9: 1149–1156.